Posted inHealth

As states try to rein in drug spending, feds slap down one bold Medicaid move

The Centers for Medicare and Medicaid have denied an attempt by Massachusetts to negotiate prices for about 1 percent of the highest-priced drugs and stop covering some of them. CMS rejected the proposal, saying Massachusetts couldn’t do what it wanted and continue to receive the deep discounts drugmakers are required by law to give state Medicaid programs. The development has implications for the rest of the country.